CureImmune's Grant

CureImmune raised a round of funding on May 19, 2017. Investors include Colorado Office of Economic Development and International Trade.

CureImmune is developing an immuno-oncology checkpoint inhibitor drug that is a stable small molecule, inexpensive to manufacture, easy to store and ship, and that can be administered at home.…

Articles about CureImmune's Grant: